Stock Report

Download full stock data and analysis for free Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

ABIOMED Inc (ABMD) Key Ratios

Stock Card factsheet share-fund-plan-icon

$381.02

$0.00 (0.00%)

As on 23-Dec-2022 09:30EDT

Market cap

info icon

$17,181 Mln

Revenue (TTM)

info icon

$1,074 Mln

P/E Ratio

info icon

65.4

P/B Ratio

info icon

11.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -4.05 7.16 10.32 9.40 16.31
EBIT 198.14 226.16 105.23 15.37 29.09
Net Profit 94.55 86.35 78.85 6.50 23.67
EPS 94.55 86.35 79.56 6.50 23.49
Book Value -- -- 13.06 17.07 26.61
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-22Mar-21
EBIT-Margin info 29.2829.8240.5423.3034.01
Net Margin info 20.4822.4622.9612.6224.89
Return on equity info 16.2520.0517.539.6418.83
Return on Capital info 16.2519.99--9.6418.83
Return on Assets info 14.3817.6115.358.6216.64
Debt to Equity (x) info ----0.00----

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
--
9.64
18.83
20.28
31.85
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

17.53

Higher than Peers by 6.48

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
17.53
9.64
18.83
20.28
31.85
Peer Median
11.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

15.35

Higher than Peers by 12.96

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
15.35
8.62
16.64
17.88
28.14
Peer Median
2.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

40.54

Higher than Peers by 37.53

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
40.54
23.30
34.01
30.54
34.23
Peer Median
3.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

22.96

Higher than Peers by 20.98

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
22.96
12.62
24.89
23.93
32.06
Peer Median
1.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

10.32

Lower than Peers by 1.16

Year on year growth in net sales

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
10.32
0.22
0.01
0.09
0.30
Peer Median
11.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

105.23

Higher than Peers by 109.60

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
105.23
-16.59
12.22
-2.48
64.15
Peer Median
-4.37
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

78.85

Higher than Peers by 81.67

Year on year growth in profit after tax

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
78.85
-39.47
11.09
-21.62
130.91
Peer Median
-2.81
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

79.56

Higher than Peers by 81.44

Year on year growth in earnings per share

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
79.56
-0.39
0.11
-0.22
1.31
Peer Median
-1.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

11.21

Higher than Peers by 6.13

Year on year growth in book value per share

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
11.21
--
--
--
--
Peer Median
5.08
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
--
--
--
--
--
Peer Median
0.71
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

7.93

Higher than Peers by 6.48

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
7.93
7.05
6.11
4.82
6.39
Peer Median
1.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

7.17

Higher than Peers by 5.61

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
7.17
6.37
5.48
4.14
5.63
Peer Median
1.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

4.62

Lower than Peers by 0.22

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
4.62
4.82
--
--
--
Peer Median
4.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

8.80

Lower than Peers by 0.54

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
8.80
8.78
11.47
10.07
11.80
Peer Median
9.34
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.62

Lower than Peers by 0.77

Sales / Average Total Assets

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
0.62
0.65
0.63
0.74
0.84
Peer Median
1.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
--
33.24
39.18
38.11
38.17
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
--
169.89
193.05
206.43
184.85
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
--
68.12
76.27
78.41
78.58
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
--
135.01
155.96
166.13
144.44
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

65.36

Higher than Peers by 29.64

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
65.36
111.62
65.01
32.89
50.72
Peer Median
35.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

11.13

Higher than Peers by 8.77

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
11.13
10.14
11.03
6.27
14.02
Peer Median
2.36
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
--
--
--
--
--
Peer Median
0.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

57.94

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
57.94
53.93
45.08
22.49
45.57
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

17,181

Higher than Peers by 12,609

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
ABIOMED Inc (ABMD)
17,181
--
--
--
--
Peer Median
4,572
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...